ClinicalTrials.govpublic full text
Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia
covid19, intensive care unit, deferoxamine, tocilizumab, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 860283
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.